Controlled synthesis of camptothecin-polylactide conjugates and nanoconjugates
about
Drug-Initiated Synthesis of Polymer Prodrugs: Combining Simplicity and Efficacy in Drug DeliverySynthesis of water-soluble camptothecin-polyoxetane conjugates via click chemistryPolylactide-cyclosporin A nanoparticles for targeted immunosuppression.Polymeric nanoparticles with precise ratiometric control over drug loading for combination therapyAnticancer Camptothecin-N-Poly(lactic acid) Nanoconjugates with Facile Hydrolysable Linker.Shape Control in Engineering of Polymeric Nanoparticles for Therapeutic Delivery.Redox-Responsive Self-Assembled Chain-Shattering Polymeric Therapeutics.Immunosuppressive Activity of Size-Controlled PEG-PLGA Nanoparticles Containing Encapsulated Cyclosporine ASynthesis of water-soluble poly(α-hydroxy acids) from living ring-opening polymerization of O-benzyl-L-serine carboxyanhydrides.Drug-initiated ring-opening polymerization of O-carboxyanhydrides for the preparation of anticancer drug-poly(O-carboxyanhydride) nanoconjugatesPolymeric Nanomedicines Based on Poly(lactide) and Poly(lactide-co-glycolide).Chain-shattering polymeric therapeutics with on-demand drug-release capabilitySmart chemistry in polymeric nanomedicine.Enzymatic polymerization of cyclic monomers in ionic liquids as a prospective synthesis method for polyesters used in drug delivery systems.Hydroxyethyl starch-10-hydroxy camptothecin conjugate: synthesis, pharmacokinetics, cytotoxicity and pharmacodynamics research.Doxorubicin conjugate of poly(ethylene glycol)-block-polyphosphoester for cancer therapy.Erythrocyte membrane-cloaked polymeric nanoparticles for controlled drug loading and release.Microfluidic approach for highly efficient synthesis of heparin-based bioconjugates for drug delivery.Fabrication and optimization of camptothecin loaded Eudragit S 100 nanoparticles by Taguchi L4 orthogonal array design.PEG-Polypeptide Dual Brush Block Copolymers: Synthesis and Application in Nanoparticle Surface PEGylation.Formation of nanoparticles by cooperative inclusion between (S)-camptothecin-modified dextrans and β-cyclodextrin polymers.Drug-Initiated, Controlled Ring-Opening Polymerization for the Synthesis of Polymer-Drug Conjugates.Redox-responsive, core-cross-linked micelles capable of on-demand, concurrent drug release and structure disassembly.Evaluation of the cytotoxic effect of camptothecin solid lipid nanoparticles on MCF7 cells.Rapidly cell-penetrating and reductive milieu-responsive nanoaggregates assembled from an amphiphilic folate-camptothecin prodrug for enhanced drug delivery and controlled release.Lactide polymerization catalyzed by Mg and Zn diketiminate complexes with flexible ligand frameworks.[Polymer nanoparticles for the delivery of anticancer drug].Nanoparticles with high payloads of pipemidic acid, a poorly soluble crystalline drug: drug-initiated polymerization and self-assembly approach.Self-stabilized, hydrophobic or PEGylated paclitaxel polymer prodrug nanoparticles for cancer therapyStructure–cytotoxicity relationship of drug-initiated polymer prodrug nanoparticlesRecent trends in the design of anticancer polymer prodrug nanocarriersWell-controlled synthesis of boronic-acid functionalised poly(lactide)s: a versatile platform for biocompatible polymer conjugates and sensors
P2860
Q26752989-40032168-4696-47D7-95A1-F1186EB195BDQ30572775-3BB47B2F-2585-4736-B603-E503873D5789Q34378940-74F035D1-4553-4FF4-8EAB-C9A2AD2A4148Q35141276-53ACA314-9361-4777-9184-A099B4B8874DQ35628729-84B657C5-7DBE-4809-8D7F-920D99DE435DQ35801327-1142BB61-9FE5-495D-9A1E-FBF797F8C761Q35801338-E48DB419-F254-4EC5-9B31-4F6789007D6EQ35876168-53AD962E-D58A-43B5-BD10-303FD84605A4Q36562694-9CB0E9F1-7832-47DA-BF7D-917A06497ACBQ36899044-B91905E7-C5EA-4A8D-B45F-C176768B9F98Q37056787-E16E2794-44B2-41A9-B7F8-4A1FD2E6275CQ37240107-0DD8C711-39DC-4A70-8EB0-6FED6F47E874Q38221776-88A476BF-C9B0-4846-88C0-266B6C122381Q38302750-93FE5A76-E02E-435C-A0BD-0676B74CA446Q38994506-C43F201D-33A1-4D46-8D6B-A2FBC55A132EQ39125938-06CAA86B-F15B-4476-8DC8-8EFE3D6158AAQ39194505-9B67F04D-4008-40AA-990E-8E879B2806D3Q39434344-2A30A210-9FF1-468E-9908-E57A0DDD44CAQ40642201-99D00D30-D0CE-4A8F-9CFB-3BC5C19DEFB3Q41911787-B627D22E-9FEE-4629-87FA-D8F83912D3B2Q41955218-EA64727D-A696-4FB9-9B25-13AD3524FC03Q42978607-4C13FCEF-758A-401C-A7FF-A4719BA26318Q43006670-535BE30C-67DA-42C7-A6BF-795BA24069FEQ44711871-D19A3462-7298-43F6-9DD6-AF5EE5D76234Q48050461-2DBD6815-EB22-42F9-B3FF-13F7C801BBF7Q50460019-32973649-006E-4496-924F-736CFEB69F94Q53549534-CB5137F7-C698-43F6-A3DD-0D95ED24BE86Q54959311-A3BAAACA-8060-4853-89B3-0445C713BFBBQ57676452-677DAE32-6C4A-4212-9655-D1780A411A86Q57676465-FF0BBC1C-6EA9-4F67-946A-A6AF1AE78F04Q57676488-D0514E22-C461-4477-8FFD-ACAF6F45A10BQ57760992-B3609293-0B58-46A1-B584-57DD45CD9F52
P2860
Controlled synthesis of camptothecin-polylactide conjugates and nanoconjugates
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Controlled synthesis of camptothecin-polylactide conjugates and nanoconjugates
@ast
Controlled synthesis of camptothecin-polylactide conjugates and nanoconjugates
@en
type
label
Controlled synthesis of camptothecin-polylactide conjugates and nanoconjugates
@ast
Controlled synthesis of camptothecin-polylactide conjugates and nanoconjugates
@en
prefLabel
Controlled synthesis of camptothecin-polylactide conjugates and nanoconjugates
@ast
Controlled synthesis of camptothecin-polylactide conjugates and nanoconjugates
@en
P2860
P356
P1476
Controlled synthesis of camptothecin-polylactide conjugates and nanoconjugates
@en
P2093
Jianjun Cheng
P2860
P304
P356
10.1021/BC900356G
P50
P577
2010-01-01T00:00:00Z